cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension.
cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension.
复制标题
肾性高血压中降低心肌细胞 O2 消耗的 cGMP 水平发生改变。
DOI:
10.1152/ajpheart.1997.273.4.h1949
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Weiss,HR
中科院分区:
文献类型:
--
作者:
Straznicka,M;Gong,G;Tse,J;Scholz,PM;Weiss,HR
We tested the hypothesis that cardiac myocytes from hypertensive (one kidney, one clip; 1K,1C) cardiac-hypertrophied rabbits require higher guanosine 3′,5′-cyclic monophosphate (cGMP) to similarly lower O2consumption than control myocytes and that this effect is caused by differences in guanylate cyclase activity. Using isolated myocytes from control and 1K,1C New Zealand White rabbits, we obtained O2consumption (nl O2⋅ min−1⋅ 105cells) and cGMP (fmol/105cells) levels after stimulation of guanylate cyclase with nitroprusside, CO, or guanylin (10−8–10−5M). Soluble guanylate cyclase activity was also determined. Basal cGMP was elevated in 1K,1C vs. control (176 ± 28 vs. 85 ± 13) myocytes. cGMP increased in 1K,1C and control myocytes after stimulation with nitroprusside, CO, and guanylin. Guanylate cyclase activity in 1K,1C vs. control myocytes was not statistically different. Basal O2consumption in 1K,1C vs. control myocytes was comparable (307 ± 1 vs. 299 ± 22). O2consumption was similarly decreased when guanylate cyclase was stimulated. Control regression equations correlating cGMP and O2consumption were O2consumption = −1.46 ⋅ [cGMP] + 444.65 (r= 0.96) for CO, O2consumption = −0.58 ⋅ [cGMP] + 328.48 (r= 0.82) for nitroprusside, and O2consumption = −1.25 ⋅ [cGMP] + 389.15 (r= 0.88) for guanylin. The 1K,1C regression equations were O2consumption = −1.36 ⋅ [cGMP] + 537.81 (r= 0.97) for CO, O2consumption = −0.23 ⋅ [cGMP] + 307.30 (r= 0.88) for nitroprusside, and O2consumption = −1.27 ⋅ [cGMP] + 502.91 (r= 0.89) for guanylin. These data indicate that 1K,1C hypertrophic myocytes had higher cGMP than controls at every level of O2consumption. This effect was not caused by differences in basal or maximal guanylate cyclase activity.